NO167359C - Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus. - Google Patents

Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.

Info

Publication number
NO167359C
NO167359C NO85854460A NO854460A NO167359C NO 167359 C NO167359 C NO 167359C NO 85854460 A NO85854460 A NO 85854460A NO 854460 A NO854460 A NO 854460A NO 167359 C NO167359 C NO 167359C
Authority
NO
Norway
Prior art keywords
hepatitis
virus
procedure
preparation
vaccine against
Prior art date
Application number
NO85854460A
Other languages
English (en)
Norwegian (no)
Other versions
NO167359B (no
NO854460L (no
Inventor
David R Milich
Frank V Chisari
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/588,122 external-priority patent/US4599230A/en
Priority claimed from US06/587,983 external-priority patent/US4599231A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO854460L publication Critical patent/NO854460L/no
Publication of NO167359B publication Critical patent/NO167359B/no
Publication of NO167359C publication Critical patent/NO167359C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Selective Calling Equipment (AREA)
  • Air Bags (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO85854460A 1984-03-09 1985-11-08 Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus. NO167359C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/588,122 US4599230A (en) 1984-03-09 1984-03-09 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US06/587,983 US4599231A (en) 1984-03-09 1984-03-09 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
PCT/US1985/000360 WO1985004103A1 (en) 1984-03-09 1985-03-06 Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants

Publications (3)

Publication Number Publication Date
NO854460L NO854460L (no) 1986-01-08
NO167359B NO167359B (no) 1991-07-22
NO167359C true NO167359C (no) 1991-10-30

Family

ID=27080174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO85854460A NO167359C (no) 1984-03-09 1985-11-08 Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.

Country Status (11)

Country Link
EP (1) EP0155146B1 (da)
AT (1) ATE82135T1 (da)
AU (2) AU579148B2 (da)
CA (1) CA1253069A (da)
DE (1) DE3586801D1 (da)
DK (1) DK516385A (da)
FI (1) FI84558C (da)
IL (3) IL90035A (da)
NO (1) NO167359C (da)
NZ (2) NZ211356A (da)
WO (1) WO1985004103A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
JPH01500515A (ja) * 1986-06-20 1989-02-23 スクリップス　クリニック　アンド　リサーチ　ファウンデーション Ｂ型肝炎ウィルス表面抗原のプレｓ領域のｔ及びｂ細胞エピトープ
US6054438A (en) * 1987-01-07 2000-04-25 Imperial Cancer Research Technology Limited Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
AU1668788A (en) * 1987-05-26 1988-12-01 Wistar Institute, The Method of vaccination for hepatitis b virus
EP0300213A1 (en) * 1987-06-22 1989-01-25 Hexal-Pharma Gentechnik GmbH & Co. KG Hepatitis a viral peptide particle immunogens
JPH03500408A (ja) * 1987-09-04 1991-01-31 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 増強された安定性を有するペプチド複合体
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
GB9325772D0 (en) * 1993-12-16 1994-02-16 Smithkline Beecham Biolog Novel compounds
WO1997039029A2 (en) * 1996-04-18 1997-10-23 Abbott Laboratories An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
EP2298900A1 (en) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for treating intracellular diseases
JP2001508054A (ja) * 1996-12-30 2001-06-19 イノジェネティックス・ナムローゼ・フェンノートシャップ ＨＢｓＡｇ由来アネキシンＶ結合ポリペプチドおよびその使用
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.
ES2709176T3 (es) 2006-08-11 2019-04-15 Life Sciences Res Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
ES2637812T3 (es) 2008-02-14 2017-10-17 Life Sciences Research Partners Vzw Inmunoterapia dirigida a patógenos intracelulares
EP2626081B1 (en) 2008-02-14 2017-03-22 Life Sciences Research Partners VZW Immunogenic control of tumours and tumour cells
DE11787873T1 (de) 2010-11-25 2013-12-12 Imnate Sarl Immugene Peptide zur Verwendung bei der Vorbeugung und/oder Behandlung von Infektionskrankheiten, Autoimmunerkrankungen, Immunreaktionen auf Allofaktoren, allergischen Erkrankungen, Tumoren, Transplantatabstossungen und Immunreaktionen auf virale Vektoren
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
EP3308798B1 (en) * 2012-06-11 2020-09-09 Xiamen University Polypeptides and antibodies for treating hbv infection and related diseases
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
CA2995771A1 (en) 2015-09-25 2017-03-30 Imcyse Sa Improved methods and compounds for eliminating immune responses to therapeutic agents
BR112018071466A2 (pt) 2016-04-19 2019-03-19 Imcyse Sa novos peptídeos de ligação a cd1d imunogênicos
JP6955020B2 (ja) 2017-02-17 2021-10-27 シャアメン ユニバーシティ 標的ポリペプチドを提示するためのポリペプチド担体及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
LU88258I2 (da) * 1978-12-22 1994-02-03
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
EP0082789B1 (en) * 1981-12-22 1987-04-08 Baylor College of Medicine Immunological composition and method for hepatitis b virus
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
JPS5974985A (ja) * 1982-10-19 1984-04-27 Takeda Chem Ind Ltd 新規ｄｎａ
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids

Also Published As

Publication number Publication date
EP0155146A3 (en) 1988-01-20
IL74545A0 (en) 1985-06-30
DK516385D0 (da) 1985-11-08
CA1253069A (en) 1989-04-25
IL90035A (en) 1990-11-05
AU2682388A (en) 1989-05-25
FI854396A0 (fi) 1985-11-07
EP0155146A2 (en) 1985-09-18
IL74545A (en) 1990-11-05
AU623106B2 (en) 1992-05-07
AU4115985A (en) 1985-10-11
NZ227731A (en) 1990-07-26
WO1985004103A1 (en) 1985-09-26
FI84558B (fi) 1991-09-13
DK516385A (da) 1985-11-08
FI84558C (fi) 1991-12-27
NO167359B (no) 1991-07-22
NZ211356A (en) 1990-07-26
ATE82135T1 (de) 1992-11-15
FI854396L (fi) 1985-11-07
EP0155146B1 (en) 1992-11-11
NO854460L (no) 1986-01-08
DE3586801D1 (de) 1992-12-17
IL90035A0 (en) 1989-12-15
AU579148B2 (en) 1988-11-17

Similar Documents

Publication Publication Date Title
NO167359C (no) Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.
McAleer et al. Human hepatitis B vaccine from recombinant yeast
EP0271302A3 (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
IE873314L (en) T cell epitopes of the hepatitis b virus nucleocapsid¹protein
DE3671633D1 (en) Htlv iii polypeptide.
AU576223B2 (en) Lyophilized hepatitis b vaccine
PL345018A1 (en) Particles of hcv envelope proteins: use for vaccination
AU5636386A (en) Recombinant acquired immune deficiency syndrome(aids) viral envelope protein and method of testing for aids
MX26715A (es) Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas.
AU1463097A (en) Helicobacter pylori bacterioferritin
WO2001016163A3 (en) Peptide mixture and vaccine against a chronic viral infection
AU605155B2 (en) A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof
AU3422797A (en) Composition useful in preparing recombinant adenovirus vaccines
TR200003778T2 (tr) Aşıyla indüklenen hepatit B viral kültürü ve kullanım yerleri
EP0327180A3 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
EP0293201A3 (en) Method of vaccination for hepatitis b virus
ES8801127A1 (es) Un procedimiento para preparar una vacuna auto antigena en forma de virus modificado de la viruela vacuna.
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
AU6325080A (en) Vaccine for porcine transmissable gastroenteritis
Shin et al. Immunogenicity of Synthetic Peptide Specific for Major Immunogenic Determinat of Hepatitis B Surface Antigen
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
NO931821L (no) Hepatitt b vaksinepreparat som omfatter et gallesyresalt
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv